Niagen Bioscience's total assets for Q4 2024 were $68.28M, an increase of 20.80% from the previous quarter. NAGE total liabilities were $22.18M for the fiscal quarter, a 0.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.